Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
After a decade of patient followup, a National Eye Institute (NEI)-supported study reported today that radial keratotomy (RK) remained a reasonably safe and effective technique to improve distance vision.
Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventually develop multiple sclerosis (MS).
Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.
The National Eye Institute reported today that current treatments for a common, sight-threatening complication of diabetes have proved 95 percent effective in maintaining vision, but 8,000 still go blind each year from this disease.
Researchers report that donor-recipient tissue typing had no significant long-term effect on the success of corneal transplantation in a nationwide clinical study of over 400 patients at high risk for rejection.
Although commonly used, oral corticosteroids alone are ineffective in treating optic neuritis, a debilitating inflammation of the optic nerve, and actually increase a person’s risk for future attacks.
Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
Louis W. Sullivan, Secretary of Health and Human Services, has announced results of a clinical trial demonstrating a 50 percent improvement in surgical control of glaucoma in patients at high risk for blindness.
New findings from a nationwide clinical trial supported by theNational Eye Institute (NEI) provide further evidence that laser treatment is highly effective in preventing visual loss from diabetic eye disease.